Among significant news last week, Halozyme Therapeutics struck a license agreement for its INCA033989 with fellow USA-based ...

Spanish medical dermatology company Almirall (BME: ALM) has reported first-half 2026 net sales of 602.7 million euros ($687.1 ...

US pharma major Johnson & Johnson has reported positive top-line Phase III data showing that a dual bispecific antibody ...

The European Medicines Agency’s (EMA) human medicines committee (CHMP) today announced recommendations for the approval of ...

UK gene therapy company EpilepsyGTx has named Teresa Nunes as its chief medical officer, tasking her with steering lead ...

US president Donald Trump has set a countdown for tariffs on imported generic medicines, ending an exemption that had ...

A young California start-up wants to do for drug development what enterprise software did for accounting and sales: put the ...

US pharma majors Gilead Sciences and Merck & Co have reported detailed Phase III data showing that their investigational once ...

Sanofi has announced changes to its executive committee, as the French pharma major streamlines senior leadership under chief ...

French health company Opella revealed it has inaugurated a new state-of-the-art production line for Enterogermina in Mexico ...

Lonza and Engitix, a UK-based ECM-based drug discovery and development firm, today announced a licensing agreement to advance ...

Kolon TissueGene has reported that the first of two pivotal US Phase III trials of TissueGene-C (TG-C), its experimental cell ...